BRAND_ANALYSIS #ILLUMINA HEALTH & PHARMA #2 OF 26 IN HEALTH & PHARMA HIGH TENSION

Illumina

· Public · Updated 25 May 2026 11:16 UTC
#29 of 1208 overall by tension · #2 of 26 in Health & Pharma
31 High Tension
The Silent Giant
Analysis

Illumina's sentiment of 0.65 is the second-highest in today's non-tech cohort, which is striking for a genomics equipment company navigating an activist investor battle and a forced divestiture. Culture at 47 and a 15.12% stock gain suggest the scientific community's genuine respect for Illumina's technology is doing brand work that the company's boardroom chaos would otherwise undermine. The business case is complicated; the cultural case among researchers is not.

IN THE NEWS (31 articles this week)
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - PR Newswire
ILMN Technical Analysis | Trend, Signals & Chart Patterns | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
Illumina (ILMN) Valuation Check After Strong Recent Share Price Momentum - Yahoo Finance
Cultural Score
47 / 100
Business Score
78 / 100
TENSION▂▂▂▁▁▂▂▃▂▂▂▂▃▃
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▅▆▅▅▅▆▆▆▆▆▆▆▆▆
Loading...
Wikipedia Momentum 15/40
News Presence 33/35
Search InterestRedistributed to other dimensions
Stock Momentum 30/30
Market Position 16/25
Revenue Growth 15/25
Earnings Health 17/20
Price$144.41
30d Change+15.1%
Market Cap$21.8B
Profit Margin19.4%
Illumina's tension is 31. Commerce outpacing culture. sociologyofcapitalism.com/brand/illumina
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/illumina.html" width="320" height="200" frameborder="0"></iframe>